Is Novavax, the latecomer COVID vaccine, worth the wait?

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax COVID-19 vaccine in mid-October soon after it was finally recommended in the United States. Like many people with autoimmune diseases, she wants to protect herself from a potentially devastating COVID infection.

Leave A Comment

Your email address will not be published. Required fields are marked *